
About Levee Medical
Levee Medical is a Healthcare company based in Durham (United States) founded in 2021 by Bruce Choi. Urological devices for post-prostatectomy incontinence are developed by Levee Medical. Levee Medical has raised $36.15 million across 7 funding rounds. Its chief executive, as recorded, is Adam Irving. Levee Medical offers products and services including Voro Urologic Scaffold. Its focus areas include Life Sciences, Genitourinary Disorders, Medical Devices and Therapeutics. Its legal entity is Levee Medical, Inc. Its competitors include Axonics, NeuSpera Medical and American Medical Systems; 2 of its 3 listed competitors have raised funding.
Company details
Levee Medical was founded in 2021 in Durham, United States, as a developer of urological devices focused on post-prostatectomy care. The VORO urological scaffold, a bioresorbable device, is offered to address urinary incontinence in radical prostatectomy patients. Complications from surgical treatments are optimized and reduced through these innovations in the medical device sector. Operations center on device design and clinical application within urology.
- Headquarters Durham, United States
- Founders Bruce Choi
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website leveemedical.com
- Social LinkedIn
- Legal Name Levee Medical, Inc
- Total Equity Funding$36.15M (USD)
in 7 rounds
- Latest Funding Round$12M (USD), Series B
Feb 2026
Products & Services of Levee Medical
Levee Medical offers a comprehensive portfolio of products and services, including Voro Urologic Scaffold.
Absorbable implant to reduce urinary incontinence after prostatectomy.
Funding Insights of Levee Medical
Levee Medical has successfully raised a total of $36.15M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $12 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $36.15M
- Total Rounds 7
- Last Round Series B — $12M
- First Round $2.6M
(Aug 2021)
All 7 funding rounds of Levee Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2026 | $12M | Series B | – | – | – |
| Oct 2025 | $4.46M | Debt – Conventional | – | – | – |
| Feb 2025 | $14M | Series B | – | – | – |
| Sep 2023 | $4.3M | Series A | – | – | – |
| Jun 2023 | $3.45M | Debt – Conventional | – | – | – |
| Mar 2022 | $3.25M | Series A | – | – | – |
| Aug 2021 | $2.6M | Seed | – | – | – |
People of Levee Medical
2 people are tracked at Levee Medical (2 in leadership).
| Name | Role | Group |
|---|---|---|
Bruce Choi | Founder | Leadership |
Adam Irving | CEO | Leadership |
Complete people profiles for Levee Medical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Levee Medical
3 dated milestones of Levee Medical across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Levee Medical is founded.
- Funding First funding round of $2.6M.
- Funding Latest funding round, Series B, of $12.0M.
Competitors of Levee Medical
Levee Medical has 3 listed competitors in our database, 2 of them funded. They include Axonics, NeuSpera Medical and American Medical Systems.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| axonics.com | 2013 | Irvine, United States | $143.47M | 762 | Sacral neuromodulation devices are developed for urinary and bowel control. | |
| neuspera.com | 2014 | Santa Clara, United States | $123.59M | Miniaturized injectable neuromodulation devices are developed for chronic diseases. | ||
| americanmedicalsystems.com | 1972 | Minnetonka, United States | Devices for the treatment of pelvic disorders |
Detailed competitors of Levee Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genitourinary Disorders
3 companies that operate in the same segment as Levee Medical (Genitourinary Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | |||
Provider of surgical devices for vertical hernia repair and abdominal wall reconstruction | 2012 | Malvern, Pennsylvania, United States | USD 104.6 M | USD 80.28 M | 209 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Levee Medical
Complete news archive for Levee Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Levee Medical
Levee Medical was founded in 2021.
Levee Medical is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Adam Irving is the CEO of Levee Medical, as recorded in our data.
Levee Medical is a funded company, having raised a total of $36.15M across 7 funding rounds to date. The company's 1st funding round was a Seed of $2.6M, raised on Aug 2021.
Levee Medical was founded in 2021 in Durham, United States, as a developer of urological devices focused on post-prostatectomy care. The VORO urological scaffold, a bioresorbable device, is offered to address urinary incontinence in radical prostatectomy patients. Complications from surgical treatments are optimized and reduced through these innovations in the medical device sector. Operations center on device design and clinical application within urology.
Levee Medical's top competitors include Axonics, NeuSpera Medical and American Medical Systems.
Levee Medical offers Voro Urologic Scaffold.
Levee Medical operates through Levee Medical, Inc.
